A Biotech Boom: Rumored Deals, Bidding Wars, CVRs, Insider Transactions, and More! – The Special Situations Report Episode #22

A minor correction at 17:50 – meant to be 15% of all shares outstanding, not 5%.

Summary:

In this episode of the Special Situations Report, hosts Asif and Tamanna Suria discuss the latest developments in the event-driven investing world, focusing on M&A activity, stock buybacks, insider trading, spinoffs, and significant management changes. They flip the script by beginning with a number of notable C-Suite transitions, including one at Shift4 Payments that has ties to the recent showdown between Elon Musk and Donald Trump. The episode continues by covering a range of M&A deals – including the Sanofi and Vigil Neuroscience deal with an attractive CVR and a twist on the typical thrift conversion playbook when it comes to NB Bancorp. Asif and Tamanna then discuss key buybacks at companies like Autoliv and Sprinklr, and a soon to be listed spinoff. Last but not least, the episode concludes by highlighting some of the most interesting insider purchases we’ve seen all year. This includes insider buying in the middle of an active merger at Regulus Therapeutics and the second-ever purchase by a long-standing Director at Topgolf Callaway.

Keywords:

M&A, tariffs, Elon Musk, Donald Trump, Twitter, X, merger arbitrage, CVRs, bidding war, competing offers, insider buying, insider sales, buybacks, C-suite transitions, spinoffs, activists, failed mergers, management transitions, special situations, event-driven investing, markets, stocks